183 related articles for article (PubMed ID: 31076106)
1. Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma.
Wang YH; Huang S; Zhu L; Yang Q; Yang XM; Gu JR; Zhang ZG; Nie HZ; Li J
Biochem Biophys Res Commun; 2019 Jun; 514(3):632-638. PubMed ID: 31076106
[TBL] [Abstract][Full Text] [Related]
2. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.
Li X; Yu W; Qian X; Xia Y; Zheng Y; Lee JH; Li W; Lyu J; Rao G; Zhang X; Qian CN; Rozen SG; Jiang T; Lu Z
Mol Cell; 2017 Jun; 66(5):684-697.e9. PubMed ID: 28552616
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Kong Y; Cao M; Zhou H; Li H; Cui Y; Fang F; Zhang W; Li J; Zhu X; Li Q; Song T; Zhang T
Cancer Sci; 2017 Jul; 108(7):1338-1346. PubMed ID: 28387999
[TBL] [Abstract][Full Text] [Related]
4. Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.
Li X; Qian X; Lu Z
Autophagy; 2017 Oct; 13(10):1790-1791. PubMed ID: 28820290
[TBL] [Abstract][Full Text] [Related]
5. Acetate Recapturing by Nuclear Acetyl-CoA Synthetase 2 Prevents Loss of Histone Acetylation during Oxygen and Serum Limitation.
Bulusu V; Tumanov S; Michalopoulou E; van den Broek NJ; MacKay G; Nixon C; Dhayade S; Schug ZT; Vande Voorde J; Blyth K; Gottlieb E; Vazquez A; Kamphorst JJ
Cell Rep; 2017 Jan; 18(3):647-658. PubMed ID: 28099844
[TBL] [Abstract][Full Text] [Related]
6. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
[TBL] [Abstract][Full Text] [Related]
7. Acetate promotes SNAI1 expression by ACSS2-mediated histone acetylation under glucose limitation in renal cell carcinoma cell.
Yao L; Jiang L; Zhang F; Li M; Yang B; Zhang F; Guo X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458971
[TBL] [Abstract][Full Text] [Related]
8. Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.
Björnson E; Mukhopadhyay B; Asplund A; Pristovsek N; Cinar R; Romeo S; Uhlen M; Kunos G; Nielsen J; Mardinoglu A
Cell Rep; 2015 Dec; 13(9):2014-26. PubMed ID: 26655911
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory.
Mews P; Donahue G; Drake AM; Luczak V; Abel T; Berger SL
Nature; 2017 Jun; 546(7658):381-386. PubMed ID: 28562591
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-CoA Synthetase 2 Promotes Cell Migration and Invasion of Renal Cell Carcinoma by Upregulating Lysosomal-Associated Membrane Protein 1 Expression.
Yao L; Guo X; Gui Y
Cell Physiol Biochem; 2018; 45(3):984-992. PubMed ID: 29444517
[TBL] [Abstract][Full Text] [Related]
11. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET.
Yoshii Y; Waki A; Furukawa T; Kiyono Y; Mori T; Yoshii H; Kudo T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Oct; 36(7):771-7. PubMed ID: 19720289
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism.
Yoshii Y; Furukawa T; Yoshii H; Mori T; Kiyono Y; Waki A; Kobayashi M; Tsujikawa T; Kudo T; Okazawa H; Yonekura Y; Fujibayashi Y
Cancer Sci; 2009 May; 100(5):821-7. PubMed ID: 19445015
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
14. Mammalian acetate-dependent acetyl CoA synthetase 2 contains multiple protein destabilization and masking elements.
Nagati JS; Kobeissy PH; Nguyen MQ; Xu M; Garcia T; Comerford SA; Hammer RE; Garcia JA
J Biol Chem; 2021 Sep; 297(3):101037. PubMed ID: 34343565
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
16. A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling.
Nagati JS; Xu M; Garcia T; Comerford SA; Hammer RE; Garcia JA
PLoS One; 2019; 14(11):e0225105. PubMed ID: 31725783
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma.
Zhang S; He J; Jia Z; Yan Z; Yang J
Urol Oncol; 2018 May; 36(5):243.e9-243.e20. PubMed ID: 29503142
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.
Schug ZT; Peck B; Jones DT; Zhang Q; Grosskurth S; Alam IS; Goodwin LM; Smethurst E; Mason S; Blyth K; McGarry L; James D; Shanks E; Kalna G; Saunders RE; Jiang M; Howell M; Lassailly F; Thin MZ; Spencer-Dene B; Stamp G; van den Broek NJ; Mackay G; Bulusu V; Kamphorst JJ; Tardito S; Strachan D; Harris AL; Aboagye EO; Critchlow SE; Wakelam MJ; Schulze A; Gottlieb E
Cancer Cell; 2015 Jan; 27(1):57-71. PubMed ID: 25584894
[TBL] [Abstract][Full Text] [Related]
19. Acetate dependence of tumors.
Comerford SA; Huang Z; Du X; Wang Y; Cai L; Witkiewicz AK; Walters H; Tantawy MN; Fu A; Manning HC; Horton JD; Hammer RE; McKnight SL; Tu BP
Cell; 2014 Dec; 159(7):1591-602. PubMed ID: 25525877
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
